JPMorgan Healthcare is trading at 53.83 as of the 23rd of March 2025, a 0.48 percent decrease since the beginning of the trading day. The etf's open price was 54.09. JPMorgan Healthcare has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. The performance scores are derived for the period starting the 23rd of December 2024 and ending today, the 23rd of March 2025. Click here to learn more.
JPMorgan Healthcare Leaders [JDOC] is traded in USA and was established null. The fund is listed under Health. The entity is thematically classified as Health Care ETFs. JPMorgan Healthcare currently have in assets under management (AUM). , while the total return for the last year was -1.8%.
Check JPMorgan Healthcare Probability Of Bankruptcy
Geographic Allocation (%)
JPMorgan Healthcare Currency Exposure
JPMorgan Healthcare Leaders holds assets that are exposed to currency risk. As an investor, you have to ensure that the increase in value or dividend from foreign constituents of JPMorgan Healthcare will not be offset by an unfavorable exchange rate and will not cancel out the return on assets from different countries. In other words, assess how much of your investment depends on the development of foreign currencies before you invest in JPMorgan Healthcare Leaders.
The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in JPMorgan Healthcare. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.
When determining whether JPMorgan Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of JPMorgan Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Jpmorgan Healthcare Leaders Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Jpmorgan Healthcare Leaders Etf:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in JPMorgan Healthcare Leaders. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
The market value of JPMorgan Healthcare is measured differently than its book value, which is the value of JPMorgan that is recorded on the company's balance sheet. Investors also form their own opinion of JPMorgan Healthcare's value that differs from its market value or its book value, called intrinsic value, which is JPMorgan Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JPMorgan Healthcare's market value can be influenced by many factors that don't directly affect JPMorgan Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JPMorgan Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if JPMorgan Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JPMorgan Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.